Bluejay Diagnostics (BJDX)Director bought ~$25K
Fred S Zeidman, Director at Bluejay Diagnostics, bought ~$25K of Bluejay Diagnostics shares.
- ~$25K
- Approx. value · 13K sh @ $2.00
- 13K
- Holds after · shares reported
- Traded
- Mar 14, 2026
- Filed
- May 19, 2026
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Jan 27, 2026Company filing · Form 8-K · Shareholder rights, Bylaws or charterChanged the rights of its shareholders, and changed its bylaws, charter or fiscal year (and 2 more items)
- Mar 6, 2026Company filing · Form 8-K · ResultsReported its results
- Mar 14, 2026 · this disclosureInsider · 5 insiders in a week, a first since 2022Director purchased ~$25K of BJDX shares in the open market
What came next
- Mar 14, 2026Company filing · Form 8-K · Material agreement, Unregistered sharesSigned an important agreement, and sold new shares without registering them
- Mar 14, 2026Insider · 4 peopleInsiders: 4 purchases (~$100K)
- May 7, 2026Company filing · Form 8-K · ResultsReported its results
- May 27, 2026Company filing · Form 8-K · Material agreement, Reg FDSigned an important agreement, and shared information with investors
- Jun 2, 2026Company filing · Form 8-K · Material agreement, Unregistered sharesSigned an important agreement, and sold new shares without registering them (and 1 more item)
- Jun 9, 2026Company filing · Form 8-K · Executive change, Shareholder voteChanged a top executive or board member, and held a shareholder vote“On June 9, 2026, Bluejay Diagnostics, Inc. (the “Company”) held its 2026 annual meeting of stockholders (the “Annual Meeting”). At the Annual Meeting, the Company’s stockholders approved Amendment No. 1 (the “Plan Amendment”) to the Bluejay Diagnostics, Inc. 2021 Stock Plan (the “Stock Plan”).”
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Bluejay Diagnostics
For Bluejay Diagnostics, OQRO holds 2 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its BJDX page.
How this filing works
Other disclosures at Bluejay Diagnostics
- SEC Form 4Jul 13, 2026
- SEC Form 4Jul 13, 2026
- SEC Form 4May 19, 2026
- SEC Form 4May 19, 2026
- SEC Form 4May 19, 2026
- SEC Form 4May 19, 2026
Everything OQRO holds on this company is on its BJDX page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
